2026 Annual Meeting | PL6 - Contemporary Clinical Issues Plenary Session
| 09:15 AM - 09:25 AM CDT | Speaker |
Presenter: AMT-130 Huntington’s Disease Gene Therapy: Clinical Study Outcomes at 3 Years
Victor W. Sung, MD |
| 09:25 AM - 09:35 AM CDT | Speaker |
Discussant: AMT-130 Huntington’s Disease Gene Therapy: Clinical Study Outcomes at 3 Years
Yvette Bordelon, MD, PhD, FAAN |
| 09:35 AM - 09:45 AM CDT | Speaker |
Presenter: Bridging the Knowledge Gap: Real-world Implementation of an AI Clinical Assistant in Neurology
Mikael Guzman Karlsson, MD, PhD |
| 09:45 AM - 09:55 AM CDT | Speaker |
Disussant: Bridging the Knowledge Gap: Real-world Implementation of an AI Clinical Assistant in Neurology
Lidia Maria V. Moura, MD, PhD, MPH, FAAN |
| 09:55 AM - 10:05 AM CDT | Speaker |
Presenter: Efficacy and Safety of Tolebrutinib Versus Placebo in Primary Progressive Multiple Sclerosis: Results from the Phase 3 PERSEUS Trial
Robert J. Fox, MD, FAAN |
| 10:05 AM - 10:15 AM CDT | Speaker |
Discussant: Efficacy and Safety of Tolebrutinib Versus Placebo in Primary Progressive Multiple Sclerosis: Results from the Phase 3 PERSEUS Trial
Farrah J. Mateen, MD, PhD, FAAN |
| 10:15 AM - 10:25 AM CDT | Speaker |
Presenter: Lifestyle Interventions vs. Monoclonal Antibodies in Mild Cognitive Impairment and Early Alzheimer’s Disease: A Comparative Review of Randomized Controlled Trials
Majid Fotuhi, MD, PhD |
| 10:25 AM - 10:35 AM CDT | Speaker |
Discussant: Lifestyle Interventions vs. Monoclonal Antibodies in Mild Cognitive Impairment and Early Alzheimer’s Disease: A Comparative Review of Randomized Controlled Trials
Neelum T. Aggarwal, MD |
| 10:35 AM - 10:45 AM CDT | Speaker |
Presenter: Enhancing Glymphatic Transport via Vasopressin: Implications of Neurodegenerative Disease and Drug Delivery
Eman Hamed, MD, PhD |
| 10:45 AM - 10:55 AM CDT | Speaker |
Discussant: Enhancing Glymphatic Transport via Vasopressin: Implications of Neurodegenerative Disease and Drug Delivery
Humberto Mestre, MD, PhD |
| Chad Hales, MD, PhD, FAAN | The institution of Dr. Hales has received research support from BrightFocus foundation. The institution of Dr. Hales has received research support from NIH. The institution of Dr. Hales has received research support from State of Georgia. Dr. Hales has a non-compensated relationship as a committee member with AAN that is relevant to AAN interests or activities. |
| Robert J. Fox, MD, FAAN | Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care. |
| Majid Fotuhi, MD, PhD | Dr. Fotuhi has nothing to disclose. |
| Lidia Maria V. Moura, MD, PhD, MPH, FAAN | Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Moura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America . The institution of Dr. Moura has received research support from NIH - NIA and NINDS. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Expert Advisor with Epilepsy Foundation . |
| Victor W. Sung, MD | Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Neuroscience. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Sung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. |
| Mikael Guzman Karlsson, MD, PhD | An immediate family member of Dr. Guzman Karlsson has received personal compensation for serving as an employee of Ventyx Biosciences, Inc.. |
| Eman Hamed, MD, PhD | Dr. Hamed has nothing to disclose. |
| Farrah J. Mateen, MD, PhD, FAAN | Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care. |
| Humberto Mestre, MD, PhD | The institution of Dr. Mestre has received research support from Brain Aneurysm Foundation. The institution of Dr. Mestre has received research support from National Institute of Health. Dr. Mestre has received intellectual property interests from a discovery or technology relating to health care. |
| Neelum T. Aggarwal, MD | Dr. Aggarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant with AtWHealth . Dr. Aggarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with VCU Health. |
| Yvette Bordelon, MD, PhD, FAAN | Dr. Bordelon has nothing to disclose. |